Ion Beam Applications S.A. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
212,512.00
220,577.00
270,357.00
328,774.00
287,421.00
208,440
Cost of Goods Sold (COGS) incl. D&A
124,845.00
125,483.00
156,842.00
190,213.00
192,502.00
139,332
Gross Income
87,667.00
95,094.00
113,515.00
138,561.00
94,919.00
69,108
SG&A Expense
70,068.00
73,163.00
84,102.00
101,974.00
106,704.00
68,223
EBIT
15,654.00
21,766.00
35,666.00
36,608.00
12,558.00
885
Unusual Expense
14,135.00
753.00
3,196.00
1,340.00
2,840.00
4,621
Non Operating Income/Expense
693.00
3,759.00
34,482.00
5,703.40
2,797.00
1,951
Interest Expense
3,217.00
2,694.00
2,006.00
1,924.00
1,965.00
3,718
Pretax Income
2,818.00
24,046.00
65,314.00
27,754.00
19,698.00
5,152
Income Tax
3,384.00
3,413.00
3,930.00
3,359.00
19,526.00
2,420
Equity in Affiliates
3,226.00
6,873.00
122.00
145.00
92.00
-
Consolidated Net Income
4,098.00
20,586.00
61,262.00
24,540.00
39,132.00
7,572
Net Income
4,098.00
20,586.00
61,262.00
24,540.00
39,132.00
7,572
Net Income After Extraordinaries
7,186.00
16,878.00
61,335.00
24,640.00
39,063.00
10,743
Net Income Available to Common
1,010.00
24,294.00
61,189.00
24,440.00
39,201.00
4,401
EPS (Basic)
0.04
0.89
2.17
0.85
1.34
0.15
Basic Shares Outstanding
26,792.30
27,319.60
28,171.80
28,748.80
29,171.40
29,320.20
EPS (Diluted)
0.04
0.86
2.09
0.83
1.34
0.15
Diluted Shares Outstanding
26,792.30
28,395.20
29,216.60
29,489.80
29,171.40
29,320.20
EBITDA
20,211.00
27,512.00
39,765.00
41,279.00
6,458.00
7,672
Other Operating Expense
1,945.00
165.00
6,253.00
21.00
773.00
-
Non-Operating Interest Income
3,823.00
462.00
368.00
113.40
462.00
351
Other After Tax Income (Expense)
7,074.00
-
-
-
-
-

About Ion Beam Applications

View Profile
Address
3, chemin du Cyclotron
Louvain-la-Neuve BU 1348
Belgium
Employees -
Website http://www.iba-worldwide.com
Updated 07/08/2019
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. It operates through the following segments: Proton Therapy and Other Accelerators, and Dosimetry. The Proton Therapy and Other Accelerators segment develops and fabricates medical and industrial particle accelerators and proton therapy systems.